IL227853A - Test for autoantibody for anti-tnfα drugs - Google Patents

Info

Publication number

IL227853A

IL227853A IL227853A IL22785313A IL227853A IL 227853 A IL227853 A IL 227853A IL 227853 A IL227853 A IL 227853A IL 22785313 A IL22785313 A IL 22785313A IL 227853 A IL227853 A IL 227853A

Authority

IL

Israel

Prior art keywords

drug

labeled

tnfa

sample

haca

Prior art date

2011-02-17

Links

• Espacenet
• Global Dossier
• Discuss

• 239000003814 drug Substances 0.000 title claims description 449
• 229940079593 drug Drugs 0.000 title claims description 439
• 238000003556 assay Methods 0.000 title description 217
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 152
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 152
• 238000000034 method Methods 0.000 claims description 124
• 238000002560 therapeutic procedure Methods 0.000 claims description 117
• 239000002253 acid Substances 0.000 claims description 67
• 230000001965 increasing effect Effects 0.000 claims description 39
• 238000001542 size-exclusion chromatography Methods 0.000 claims description 34
• 230000003472 neutralizing effect Effects 0.000 claims description 33
• 238000010494 dissociation reaction Methods 0.000 claims description 28
• 230000005593 dissociations Effects 0.000 claims description 28
• 230000001988 toxicity Effects 0.000 claims description 27
• 231100000419 toxicity Toxicity 0.000 claims description 27
• 239000003018 immunosuppressive agent Substances 0.000 claims description 21
• 230000003247 decreasing effect Effects 0.000 claims description 18
• 239000007850 fluorescent dye Substances 0.000 claims description 14
• 239000003795 chemical substances by application Substances 0.000 claims description 12
• 229940125721 immunosuppressive agent Drugs 0.000 claims description 11
• 210000002966 serum Anatomy 0.000 description 226
• 239000000523 sample Substances 0.000 description 222
• 229960000598 infliximab Drugs 0.000 description 173
• 229960002964 adalimumab Drugs 0.000 description 101
• 241000282414 Homo sapiens Species 0.000 description 81
• 108090000623 proteins and genes Proteins 0.000 description 71
• 238000011282 treatment Methods 0.000 description 65
• 102000004169 proteins and genes Human genes 0.000 description 62
• 101001125026 Homo sapiens Nucleotide-binding oligomerization domain-containing protein 2 Proteins 0.000 description 60
• 238000001514 detection method Methods 0.000 description 60
• 102100029441 Nucleotide-binding oligomerization domain-containing protein 2 Human genes 0.000 description 56
• 235000018102 proteins Nutrition 0.000 description 55
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 53
• 238000004128 high performance liquid chromatography Methods 0.000 description 49
• 229940116176 remicade Drugs 0.000 description 46
• 239000000427 antigen Substances 0.000 description 43
• 108091007433 antigens Proteins 0.000 description 43
• 102000036639 antigens Human genes 0.000 description 43
• 238000002651 drug therapy Methods 0.000 description 43
• 239000002773 nucleotide Substances 0.000 description 43
• 125000003729 nucleotide group Chemical group 0.000 description 43
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 42
• 238000004458 analytical method Methods 0.000 description 40
• 230000027455 binding Effects 0.000 description 39
• -1 hydrochloroquine Chemical compound 0.000 description 39
• 230000001225 therapeutic effect Effects 0.000 description 38
• 201000010099 disease Diseases 0.000 description 36
• 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 36
• 239000000243 solution Substances 0.000 description 35
• 239000012099 Alexa Fluor family Substances 0.000 description 34
• 238000002965 ELISA Methods 0.000 description 34
• 206010039073 rheumatoid arthritis Diseases 0.000 description 34
• 108700028369 Alleles Proteins 0.000 description 33
• 102000004127 Cytokines Human genes 0.000 description 33
• 108090000695 Cytokines Proteins 0.000 description 33
• 238000006243 chemical reaction Methods 0.000 description 33
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 31
• 230000009266 disease activity Effects 0.000 description 30
• 238000012544 monitoring process Methods 0.000 description 29
• 108090000765 processed proteins & peptides Proteins 0.000 description 28
• 239000007791 liquid phase Substances 0.000 description 26
• 150000001413 amino acids Chemical class 0.000 description 25
• 102000004196 processed proteins & peptides Human genes 0.000 description 25
• 230000000694 effects Effects 0.000 description 24
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 24
• 229940048921 humira Drugs 0.000 description 23
• 229920001184 polypeptide Polymers 0.000 description 23
• 210000004027 cell Anatomy 0.000 description 22
• 238000005259 measurement Methods 0.000 description 22
• 230000004044 response Effects 0.000 description 22
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
• 229940104302 cytosine Drugs 0.000 description 21
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 21
• 230000035945 sensitivity Effects 0.000 description 21
• 231100000673 dose–response relationship Toxicity 0.000 description 20
• 239000012634 fragment Substances 0.000 description 20
• 238000011534 incubation Methods 0.000 description 20
• 239000002953 phosphate buffered saline Substances 0.000 description 20
• 230000019491 signal transduction Effects 0.000 description 20
• 239000000090 biomarker Substances 0.000 description 19
• 230000014509 gene expression Effects 0.000 description 19
• 239000013610 patient sample Substances 0.000 description 19
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 18
• 229960002170 azathioprine Drugs 0.000 description 18
• 230000002757 inflammatory effect Effects 0.000 description 18
• 230000014759 maintenance of location Effects 0.000 description 18
• 210000001519 tissue Anatomy 0.000 description 18
• 101150083031 Nod2 gene Proteins 0.000 description 17
• 208000035475 disorder Diseases 0.000 description 17
• 230000006870 function Effects 0.000 description 17
• 239000003102 growth factor Substances 0.000 description 17
• 238000006467 substitution reaction Methods 0.000 description 17
• 208000011231 Crohn disease Diseases 0.000 description 16
• 206010061218 Inflammation Diseases 0.000 description 16
• 238000012896 Statistical algorithm Methods 0.000 description 16
• 230000004054 inflammatory process Effects 0.000 description 16
• 230000000670 limiting effect Effects 0.000 description 16
• 108020004999 messenger RNA Proteins 0.000 description 16
• 230000015572 biosynthetic process Effects 0.000 description 15
• 230000010354 integration Effects 0.000 description 15
• 239000000203 mixture Substances 0.000 description 15
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
• 102100032752 C-reactive protein Human genes 0.000 description 14
• 102100026236 Interleukin-8 Human genes 0.000 description 14
• 230000004913 activation Effects 0.000 description 14
• 235000001014 amino acid Nutrition 0.000 description 14
• 230000007717 exclusion Effects 0.000 description 14
• 108010074051 C-Reactive Protein Proteins 0.000 description 13
• 102000019034 Chemokines Human genes 0.000 description 13
• 108010012236 Chemokines Proteins 0.000 description 13
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 13
• 108010040721 Flagellin Proteins 0.000 description 13
• 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 13
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 13
• 102000054727 Serum Amyloid A Human genes 0.000 description 13
• 230000008901 benefit Effects 0.000 description 13
• 230000007423 decrease Effects 0.000 description 13
• 238000010790 dilution Methods 0.000 description 13
• 239000012895 dilution Substances 0.000 description 13
• 230000001404 mediated effect Effects 0.000 description 13
• 229960000485 methotrexate Drugs 0.000 description 13
• 210000000440 neutrophil Anatomy 0.000 description 13
• 239000012071 phase Substances 0.000 description 13
• 239000012103 Alexa Fluor 488 Substances 0.000 description 12
• 241001408449 Asca Species 0.000 description 12
• 208000023275 Autoimmune disease Diseases 0.000 description 12
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 12
• 108700028909 Serum Amyloid A Proteins 0.000 description 12
• 230000008859 change Effects 0.000 description 12
• 239000003550 marker Substances 0.000 description 12
• 210000002381 plasma Anatomy 0.000 description 12
• 102200146742 rs2066844 Human genes 0.000 description 12
• XGWFJBFNAQHLEF-UHFFFAOYSA-N 9-anthroic acid Chemical compound C1=CC=C2C(C(=O)O)=C(C=CC=C3)C3=CC2=C1 XGWFJBFNAQHLEF-UHFFFAOYSA-N 0.000 description 11
• 102000011767 Acute-Phase Proteins Human genes 0.000 description 11
• 108010062271 Acute-Phase Proteins Proteins 0.000 description 11
• 108090001005 Interleukin-6 Proteins 0.000 description 11
• 102000004889 Interleukin-6 Human genes 0.000 description 11
• 230000005284 excitation Effects 0.000 description 11
• 102200146596 rs2066845 Human genes 0.000 description 11
• 229930024421 Adenine Natural products 0.000 description 10
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 10
• 108010063045 Lactoferrin Proteins 0.000 description 10
• 102000010445 Lactoferrin Human genes 0.000 description 10
• 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 10
• 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 description 10
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 10
• 229960000643 adenine Drugs 0.000 description 10
• 230000007614 genetic variation Effects 0.000 description 10
• 238000003018 immunoassay Methods 0.000 description 10
• 229940124589 immunosuppressive drug Drugs 0.000 description 10
• 230000036542 oxidative stress Effects 0.000 description 10
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 9
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 9
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 9
• 108700028353 OmpC Proteins 0.000 description 9
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 9
• 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 9
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 9
• 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 9
• 238000002820 assay format Methods 0.000 description 9
• 230000001580 bacterial effect Effects 0.000 description 9
• 229940125385 biologic drug Drugs 0.000 description 9
• 229940090100 cimzia Drugs 0.000 description 9
• 230000002068 genetic effect Effects 0.000 description 9
• CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 9
• 229940078795 lactoferrin Drugs 0.000 description 9
• 235000021242 lactoferrin Nutrition 0.000 description 9
• 239000011541 reaction mixture Substances 0.000 description 9
• 229940113082 thymine Drugs 0.000 description 9
• 102000000844 Cell Surface Receptors Human genes 0.000 description 8
• 108010001857 Cell Surface Receptors Proteins 0.000 description 8
• 108010008165 Etanercept Proteins 0.000 description 8
• 108090001007 Interleukin-8 Proteins 0.000 description 8
• 108010057466 NF-kappa B Proteins 0.000 description 8
• 102000003945 NF-kappa B Human genes 0.000 description 8
• 230000003321 amplification Effects 0.000 description 8
• 230000001413 cellular effect Effects 0.000 description 8
• 229960003115 certolizumab pegol Drugs 0.000 description 8
• 238000002474 experimental method Methods 0.000 description 8
• 229960001743 golimumab Drugs 0.000 description 8
• 230000002055 immunohistochemical effect Effects 0.000 description 8
• 239000003112 inhibitor Substances 0.000 description 8
• 210000004901 leucine-rich repeat Anatomy 0.000 description 8
• 238000003199 nucleic acid amplification method Methods 0.000 description 8
• 239000007787 solid Substances 0.000 description 8
• 241000894007 species Species 0.000 description 8
• 238000012360 testing method Methods 0.000 description 8
• 210000002700 urine Anatomy 0.000 description 8
• 238000008157 ELISA kit Methods 0.000 description 7
• 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 7
• 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 7
• 108060003951 Immunoglobulin Proteins 0.000 description 7
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 7
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 7
• 210000004369 blood Anatomy 0.000 description 7
• 239000008280 blood Substances 0.000 description 7
• 238000004587 chromatography analysis Methods 0.000 description 7
• 239000000975 dye Substances 0.000 description 7
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 7
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 7
• 238000011067 equilibration Methods 0.000 description 7
• 238000009396 hybridization Methods 0.000 description 7
• 230000028993 immune response Effects 0.000 description 7
• 102000018358 immunoglobulin Human genes 0.000 description 7
• 238000002329 infrared spectrum Methods 0.000 description 7
• 230000002401 inhibitory effect Effects 0.000 description 7
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 7
• 239000002245 particle Substances 0.000 description 7
• 108010075437 phosphopeptidomannan Proteins 0.000 description 7
• 238000000926 separation method Methods 0.000 description 7
• 238000001429 visible spectrum Methods 0.000 description 7
• 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 6
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
• 108010052500 Calgranulin A Proteins 0.000 description 6
• 102000004190 Enzymes Human genes 0.000 description 6
• 108090000790 Enzymes Proteins 0.000 description 6
• 101800003838 Epidermal growth factor Proteins 0.000 description 6
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 6
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 6
• 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 6
• 102000004890 Interleukin-8 Human genes 0.000 description 6
• 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 description 6
• 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 description 6
• 241000699666 Mus <mouse, genus> Species 0.000 description 6
• 108700002045 Nod2 Signaling Adaptor Proteins 0.000 description 6
• 108091007960 PI3Ks Proteins 0.000 description 6
• 102100032442 Protein S100-A8 Human genes 0.000 description 6
• 102100032277 Serum amyloid A-1 protein Human genes 0.000 description 6
• 102100024584 Tumor necrosis factor ligand superfamily member 12 Human genes 0.000 description 6
• 238000004364 calculation method Methods 0.000 description 6
• 230000004087 circulation Effects 0.000 description 6
• 238000005516 engineering process Methods 0.000 description 6
• 229940088598 enzyme Drugs 0.000 description 6
• 229960000403 etanercept Drugs 0.000 description 6
• 238000003780 insertion Methods 0.000 description 6
• 230000037431 insertion Effects 0.000 description 6
• 230000037361 pathway Effects 0.000 description 6
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 6
• 230000002829 reductive effect Effects 0.000 description 6
• 238000007619 statistical method Methods 0.000 description 6
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 6
• 108010052495 Calgranulin B Proteins 0.000 description 5
• 108091026890 Coding region Proteins 0.000 description 5
• 108010037645 Cytokine TWEAK Proteins 0.000 description 5
• 108010065805 Interleukin-12 Proteins 0.000 description 5
• 102000013462 Interleukin-12 Human genes 0.000 description 5
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 5
• 102100032420 Protein S100-A9 Human genes 0.000 description 5
• 102000013009 Pyruvate Kinase Human genes 0.000 description 5
• 108020005115 Pyruvate Kinase Proteins 0.000 description 5
• 238000001574 biopsy Methods 0.000 description 5
• 238000004422 calculation algorithm Methods 0.000 description 5
• 238000012217 deletion Methods 0.000 description 5
• 230000037430 deletion Effects 0.000 description 5
• 239000012149 elution buffer Substances 0.000 description 5
• 239000002158 endotoxin Substances 0.000 description 5
• 229940116977 epidermal growth factor Drugs 0.000 description 5
• 208000027866 inflammatory disease Diseases 0.000 description 5
• 238000002347 injection Methods 0.000 description 5
• 239000007924 injection Substances 0.000 description 5
• 229920006008 lipopolysaccharide Polymers 0.000 description 5
• 230000009871 nonspecific binding Effects 0.000 description 5
• 230000026731 phosphorylation Effects 0.000 description 5
• 238000006366 phosphorylation reaction Methods 0.000 description 5
• 238000011002 quantification Methods 0.000 description 5
• 102000005962 receptors Human genes 0.000 description 5
• 108020003175 receptors Proteins 0.000 description 5
• 210000003296 saliva Anatomy 0.000 description 5
• 230000000405 serological effect Effects 0.000 description 5
• 239000007790 solid phase Substances 0.000 description 5
• 208000024891 symptom Diseases 0.000 description 5
• WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 5
• 238000005406 washing Methods 0.000 description 5
• 101100067974 Arabidopsis thaliana POP2 gene Proteins 0.000 description 4
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 4
• 108010055166 Chemokine CCL5 Proteins 0.000 description 4
• 108020004414 DNA Proteins 0.000 description 4
• 206010052804 Drug tolerance Diseases 0.000 description 4
• 102000001301 EGF receptor Human genes 0.000 description 4
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 4
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 4
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 4
• 102100021866 Hepatocyte growth factor Human genes 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 101100118549 Homo sapiens EGFR gene Proteins 0.000 description 4
• 101001091538 Homo sapiens Pyruvate kinase PKM Proteins 0.000 description 4
• 102000003816 Interleukin-13 Human genes 0.000 description 4
• 108090000176 Interleukin-13 Proteins 0.000 description 4
• 102000003812 Interleukin-15 Human genes 0.000 description 4
• 108090000172 Interleukin-15 Proteins 0.000 description 4
• 108010002350 Interleukin-2 Proteins 0.000 description 4
• 102000000588 Interleukin-2 Human genes 0.000 description 4
• 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 description 4
• 102000002356 Nectin Human genes 0.000 description 4
• 108060005251 Nectin Proteins 0.000 description 4
• 108091092724 Noncoding DNA Proteins 0.000 description 4
• 108010029485 Protein Isoforms Proteins 0.000 description 4
• 102000001708 Protein Isoforms Human genes 0.000 description 4
• 102100034911 Pyruvate kinase PKM Human genes 0.000 description 4
• 102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 description 4
• 101710100963 Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 description 4
• 101100123851 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HER1 gene Proteins 0.000 description 4
• 101710190759 Serum amyloid A protein Proteins 0.000 description 4
• 108010009583 Transforming Growth Factors Proteins 0.000 description 4
• 102000009618 Transforming Growth Factors Human genes 0.000 description 4
• 102100040247 Tumor necrosis factor Human genes 0.000 description 4
• 210000001789 adipocyte Anatomy 0.000 description 4
• 238000013459 approach Methods 0.000 description 4
• 239000003593 chromogenic compound Substances 0.000 description 4
• 239000011248 coating agent Substances 0.000 description 4
• 238000000576 coating method Methods 0.000 description 4
• 150000001875 compounds Chemical class 0.000 description 4
• 230000001086 cytosolic effect Effects 0.000 description 4
• 210000001035 gastrointestinal tract Anatomy 0.000 description 4
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
• 230000005847 immunogenicity Effects 0.000 description 4
• 210000001503 joint Anatomy 0.000 description 4
• 238000002372 labelling Methods 0.000 description 4
• 210000000265 leukocyte Anatomy 0.000 description 4
• 239000003446 ligand Substances 0.000 description 4
• 210000004698 lymphocyte Anatomy 0.000 description 4
• 210000002540 macrophage Anatomy 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 210000004379 membrane Anatomy 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• 239000002207 metabolite Substances 0.000 description 4
• 230000000813 microbial effect Effects 0.000 description 4
• 210000001616 monocyte Anatomy 0.000 description 4
• 238000006386 neutralization reaction Methods 0.000 description 4
• 102000039446 nucleic acids Human genes 0.000 description 4
• 108020004707 nucleic acids Proteins 0.000 description 4
• 150000007523 nucleic acids Chemical class 0.000 description 4
• 150000007524 organic acids Chemical class 0.000 description 4
• 239000000047 product Substances 0.000 description 4
• 102000027426 receptor tyrosine kinases Human genes 0.000 description 4
• 108091008598 receptor tyrosine kinases Proteins 0.000 description 4
• 238000003259 recombinant expression Methods 0.000 description 4
• 229940068638 simponi Drugs 0.000 description 4
• 238000001228 spectrum Methods 0.000 description 4
• 238000010186 staining Methods 0.000 description 4
• 108091023025 thyroid hormone binding Proteins 0.000 description 4
• 102000028501 thyroid hormone-binding Human genes 0.000 description 4
• 238000010200 validation analysis Methods 0.000 description 4
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
• 108010033760 Amphiregulin Proteins 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• 241000894006 Bacteria Species 0.000 description 3
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 3
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 3
• 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 description 3
• 238000012286 ELISA Assay Methods 0.000 description 3
• 102400000686 Endothelin-1 Human genes 0.000 description 3
• 101800004490 Endothelin-1 Proteins 0.000 description 3
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 3
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
• 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 3
• 230000005526 G1 to G0 transition Effects 0.000 description 3
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 3
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 3
• 101000942118 Homo sapiens C-reactive protein Proteins 0.000 description 3
• 101001060261 Homo sapiens Fibroblast growth factor 7 Proteins 0.000 description 3
• 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 3
• 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 description 3
• 101001120056 Homo sapiens Phosphatidylinositol 3-kinase regulatory subunit alpha Proteins 0.000 description 3
• 101000869480 Homo sapiens Serum amyloid A-1 protein Proteins 0.000 description 3
• 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 description 3
• 101000851018 Homo sapiens Vascular endothelial growth factor receptor 1 Proteins 0.000 description 3
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
• 206010020751 Hypersensitivity Diseases 0.000 description 3
• 102100036721 Insulin receptor Human genes 0.000 description 3
• 102100040019 Interferon alpha-1/13 Human genes 0.000 description 3
• 102000000589 Interleukin-1 Human genes 0.000 description 3
• 108010002352 Interleukin-1 Proteins 0.000 description 3
• 108090000174 Interleukin-10 Proteins 0.000 description 3
• 108010065637 Interleukin-23 Proteins 0.000 description 3
• 102000013264 Interleukin-23 Human genes 0.000 description 3
• 102000010781 Interleukin-6 Receptors Human genes 0.000 description 3
• 108010038501 Interleukin-6 Receptors Proteins 0.000 description 3
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 3
• 108010068342 MAP Kinase Kinase 1 Proteins 0.000 description 3
• 108010025020 Nerve Growth Factor Proteins 0.000 description 3
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
• 102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 description 3
• 101710132081 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Proteins 0.000 description 3
• 102100026169 Phosphatidylinositol 3-kinase regulatory subunit alpha Human genes 0.000 description 3
• 102100035846 Pigment epithelium-derived factor Human genes 0.000 description 3
• 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 3
• 108010013381 Porins Proteins 0.000 description 3
• 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 3
• 108091036066 Three prime untranslated region Proteins 0.000 description 3
• 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 239000013543 active substance Substances 0.000 description 3
• 230000001154 acute effect Effects 0.000 description 3
• 230000002411 adverse Effects 0.000 description 3
• 230000000845 anti-microbial effect Effects 0.000 description 3
• 229940125644 antibody drug Drugs 0.000 description 3
• 239000004599 antimicrobial Substances 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 238000011461 current therapy Methods 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 238000010828 elution Methods 0.000 description 3
• 229940073621 enbrel Drugs 0.000 description 3
• 102000015694 estrogen receptors Human genes 0.000 description 3
• 108010038795 estrogen receptors Proteins 0.000 description 3
• 239000000284 extract Substances 0.000 description 3
• 210000003495 flagella Anatomy 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 230000035876 healing Effects 0.000 description 3
• 230000001900 immune effect Effects 0.000 description 3
• 229940099472 immunoglobulin a Drugs 0.000 description 3
• 229940027941 immunoglobulin g Drugs 0.000 description 3
• 238000001802 infusion Methods 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 3
• 150000007522 mineralic acids Chemical class 0.000 description 3
• 229940053128 nerve growth factor Drugs 0.000 description 3
• 238000005457 optimization Methods 0.000 description 3
• 230000001590 oxidative effect Effects 0.000 description 3
• 230000007310 pathophysiology Effects 0.000 description 3
• 238000010647 peptide synthesis reaction Methods 0.000 description 3
• 238000002823 phage display Methods 0.000 description 3
• 102000007739 porin activity proteins Human genes 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 238000002764 solid phase assay Methods 0.000 description 3
• 229940124597 therapeutic agent Drugs 0.000 description 3
• 238000000825 ultraviolet detection Methods 0.000 description 3
• 210000005253 yeast cell Anatomy 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• HMWAJFNEGAJETK-UHFFFAOYSA-N 1-[6-(dimethylamino)naphthalen-2-yl]prop-2-en-1-one Chemical compound C1=C(C(=O)C=C)C=CC2=CC(N(C)C)=CC=C21 HMWAJFNEGAJETK-UHFFFAOYSA-N 0.000 description 2
• CNWINRVXAYPOMW-FCNJXWMTSA-N 1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol 4,5-biphosphate Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(O)(=O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1O CNWINRVXAYPOMW-FCNJXWMTSA-N 0.000 description 2
• RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 2
• HDBQZGJWHMCXIL-UHFFFAOYSA-N 3,7-dihydropurine-2-thione Chemical compound SC1=NC=C2NC=NC2=N1 HDBQZGJWHMCXIL-UHFFFAOYSA-N 0.000 description 2
• 102100033793 ALK tyrosine kinase receptor Human genes 0.000 description 2
• 101710168331 ALK tyrosine kinase receptor Proteins 0.000 description 2
• HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
• 206010048998 Acute phase reaction Diseases 0.000 description 2
• 102000014777 Adipokines Human genes 0.000 description 2
• 108010078606 Adipokines Proteins 0.000 description 2
• 102100038778 Amphiregulin Human genes 0.000 description 2
• 102000007299 Amphiregulin Human genes 0.000 description 2
• 102100022014 Angiopoietin-1 receptor Human genes 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 2
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 2
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
• 102100023702 C-C motif chemokine 13 Human genes 0.000 description 2
• 102100023705 C-C motif chemokine 14 Human genes 0.000 description 2
• 102100023703 C-C motif chemokine 15 Human genes 0.000 description 2
• 102100023700 C-C motif chemokine 16 Human genes 0.000 description 2
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 2
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
• 102100036848 C-C motif chemokine 20 Human genes 0.000 description 2
• 102100036846 C-C motif chemokine 21 Human genes 0.000 description 2
• 102100036850 C-C motif chemokine 23 Human genes 0.000 description 2
• 102100036849 C-C motif chemokine 24 Human genes 0.000 description 2
• 102100021933 C-C motif chemokine 25 Human genes 0.000 description 2
• 102100021935 C-C motif chemokine 26 Human genes 0.000 description 2
• 102100021936 C-C motif chemokine 27 Human genes 0.000 description 2
• 102100021942 C-C motif chemokine 28 Human genes 0.000 description 2
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 2
• 102100034871 C-C motif chemokine 8 Human genes 0.000 description 2
• 102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 2
• 102100025277 C-X-C motif chemokine 13 Human genes 0.000 description 2
• 102100039435 C-X-C motif chemokine 17 Human genes 0.000 description 2
• 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 2
• 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 2
• 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 2
• 241000282465 Canis Species 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 102000021350 Caspase recruitment domains Human genes 0.000 description 2
• 108091011189 Caspase recruitment domains Proteins 0.000 description 2
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 2
• 102000001327 Chemokine CCL5 Human genes 0.000 description 2
• 241000193469 Clostridium pasteurianum Species 0.000 description 2
• 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 2
• 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 2
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
• 108010036949 Cyclosporine Proteins 0.000 description 2
• XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 2
• 102000016911 Deoxyribonucleases Human genes 0.000 description 2
• 108010053770 Deoxyribonucleases Proteins 0.000 description 2
• 101000876610 Dictyostelium discoideum Extracellular signal-regulated kinase 2 Proteins 0.000 description 2
• 241000196324 Embryophyta Species 0.000 description 2
• 102100023688 Eotaxin Human genes 0.000 description 2
• 241000283073 Equus caballus Species 0.000 description 2
• 102000003951 Erythropoietin Human genes 0.000 description 2
• 108090000394 Erythropoietin Proteins 0.000 description 2
• 102100022466 Eukaryotic translation initiation factor 4E-binding protein 1 Human genes 0.000 description 2
• 108050000946 Eukaryotic translation initiation factor 4E-binding protein 1 Proteins 0.000 description 2
• 108091006020 Fc-tagged proteins Proteins 0.000 description 2
• 241000282324 Felis Species 0.000 description 2
• KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
• 102000006395 Globulins Human genes 0.000 description 2
• 108010044091 Globulins Proteins 0.000 description 2
• 108010024636 Glutathione Proteins 0.000 description 2
• 108010053070 Glutathione Disulfide Proteins 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• 208000009329 Graft vs Host Disease Diseases 0.000 description 2
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
• 102000004858 Growth differentiation factor-9 Human genes 0.000 description 2
• 108090001086 Growth differentiation factor-9 Proteins 0.000 description 2
• 102100033067 Growth factor receptor-bound protein 2 Human genes 0.000 description 2
• 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 2
• 102000015779 HDL Lipoproteins Human genes 0.000 description 2
• 108010010234 HDL Lipoproteins Proteins 0.000 description 2
• 102100030488 HEAT repeat-containing protein 6 Human genes 0.000 description 2
• 108010033040 Histones Proteins 0.000 description 2
• 101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 2
• 101000753291 Homo sapiens Angiopoietin-1 receptor Proteins 0.000 description 2
• 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 description 2
• 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 description 2
• 101000978375 Homo sapiens C-C motif chemokine 16 Proteins 0.000 description 2
• 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 2
• 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 description 2
• 101000897486 Homo sapiens C-C motif chemokine 25 Proteins 0.000 description 2
• 101000897477 Homo sapiens C-C motif chemokine 28 Proteins 0.000 description 2
• 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 description 2
• 101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 description 2
• 101000889048 Homo sapiens C-X-C motif chemokine 17 Proteins 0.000 description 2
• 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 description 2
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 2
• 101000922020 Homo sapiens Cysteine and glycine-rich protein 1 Proteins 0.000 description 2
• 101000871017 Homo sapiens Growth factor receptor-bound protein 2 Proteins 0.000 description 2
• 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 2
• 101000956807 Homo sapiens Leukocyte tyrosine kinase receptor Proteins 0.000 description 2
• 101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 description 2
• 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 2
• 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 description 2
• 101000871708 Homo sapiens Proheparin-binding EGF-like growth factor Proteins 0.000 description 2
• 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 2
• 101000798015 Homo sapiens RAC-beta serine/threonine-protein kinase Proteins 0.000 description 2
• 101000798007 Homo sapiens RAC-gamma serine/threonine-protein kinase Proteins 0.000 description 2
• 101000864831 Homo sapiens Serine/threonine-protein kinase Sgk3 Proteins 0.000 description 2
• 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 2
• 101000830598 Homo sapiens Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 description 2
• 101000753253 Homo sapiens Tyrosine-protein kinase receptor Tie-1 Proteins 0.000 description 2
• 101000851030 Homo sapiens Vascular endothelial growth factor receptor 3 Proteins 0.000 description 2
• 101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 description 2
• 101001117143 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial Proteins 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• 102100039137 Insulin receptor-related protein Human genes 0.000 description 2
• 108010044467 Isoenzymes Proteins 0.000 description 2
• 206010023203 Joint destruction Diseases 0.000 description 2
• 102100038420 Leukocyte tyrosine kinase receptor Human genes 0.000 description 2
• 108040008097 MAP kinase activity proteins Proteins 0.000 description 2
• 102000019149 MAP kinase activity proteins Human genes 0.000 description 2
• PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
• 229920000057 Mannan Polymers 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 2
• 108010056852 Myostatin Proteins 0.000 description 2
• 102000015336 Nerve Growth Factor Human genes 0.000 description 2
• 102000001068 Neural Cell Adhesion Molecules Human genes 0.000 description 2
• 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 description 2
• 108090000742 Neurotrophin 3 Proteins 0.000 description 2
• 102100029268 Neurotrophin-3 Human genes 0.000 description 2
• 102000003683 Neurotrophin-4 Human genes 0.000 description 2
• 108090000099 Neurotrophin-4 Proteins 0.000 description 2
• 108090001145 Nuclear Receptor Coactivator 3 Proteins 0.000 description 2
• 102100022935 Nuclear receptor corepressor 1 Human genes 0.000 description 2
• 101710153661 Nuclear receptor corepressor 1 Proteins 0.000 description 2
• 108010061952 Orosomucoid Proteins 0.000 description 2
• 102000012404 Orosomucoid Human genes 0.000 description 2
• 102000008108 Osteoprotegerin Human genes 0.000 description 2
• 108010035042 Osteoprotegerin Proteins 0.000 description 2
• 102000018546 Paxillin Human genes 0.000 description 2
• ACNHBCIZLNNLRS-UHFFFAOYSA-N Paxilline 1 Natural products N1C2=CC=CC=C2C2=C1C1(C)C3(C)CCC4OC(C(C)(O)C)C(=O)C=C4C3(O)CCC1C2 ACNHBCIZLNNLRS-UHFFFAOYSA-N 0.000 description 2
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 2
• 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 2
• 108010069381 Platelet Endothelial Cell Adhesion Molecule-1 Proteins 0.000 description 2
• 102000037602 Platelet Endothelial Cell Adhesion Molecule-1 Human genes 0.000 description 2
• 102100036154 Platelet basic protein Human genes 0.000 description 2
• 102100030304 Platelet factor 4 Human genes 0.000 description 2
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
• 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 description 2
• 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 description 2
• 102100025803 Progesterone receptor Human genes 0.000 description 2
• 102100033762 Proheparin-binding EGF-like growth factor Human genes 0.000 description 2
• 102100029812 Protein S100-A12 Human genes 0.000 description 2
• 101710110949 Protein S100-A12 Proteins 0.000 description 2
• 102100032315 RAC-beta serine/threonine-protein kinase Human genes 0.000 description 2
• 102100032314 RAC-gamma serine/threonine-protein kinase Human genes 0.000 description 2
• 102100038246 Retinol-binding protein 4 Human genes 0.000 description 2
• 101710137011 Retinol-binding protein 4 Proteins 0.000 description 2
• 102000013674 S-100 Human genes 0.000 description 2
• 108700021018 S100 Proteins 0.000 description 2
• 108010044012 STAT1 Transcription Factor Proteins 0.000 description 2
• 108010017324 STAT3 Transcription Factor Proteins 0.000 description 2
• 206010040047 Sepsis Diseases 0.000 description 2
• 102100030071 Serine/threonine-protein kinase Sgk3 Human genes 0.000 description 2
• 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 2
• 102100029904 Signal transducer and activator of transcription 1-alpha/beta Human genes 0.000 description 2
• 102100024040 Signal transducer and activator of transcription 3 Human genes 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• 108010008038 Synthetic Vaccines Proteins 0.000 description 2
• 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 2
• 108700031954 Tgfb1i1/Leupaxin/TGFB1I1 Proteins 0.000 description 2
• 102000036693 Thrombopoietin Human genes 0.000 description 2
• 108010041111 Thrombopoietin Proteins 0.000 description 2
• 102100023132 Transcription factor Jun Human genes 0.000 description 2
• 206010052779 Transplant rejections Diseases 0.000 description 2
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
• 206010054094 Tumour necrosis Diseases 0.000 description 2
• 102100022007 Tyrosine-protein kinase receptor Tie-1 Human genes 0.000 description 2
• 108010046334 Urease Proteins 0.000 description 2
• 102100033179 Vascular endothelial growth factor receptor 3 Human genes 0.000 description 2
• RQQIRMLGKSPXSE-WIPMOJCBSA-N [1-acetyloxy-2-[[(2s,3r,5s,6s)-2,6-dihydroxy-3,4,5-triphosphonooxycyclohexyl]oxy-hydroxyphosphoryl]oxyethyl] acetate Chemical compound CC(=O)OC(OC(C)=O)COP(O)(=O)OC1[C@H](O)[C@H](OP(O)(O)=O)C(OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1O RQQIRMLGKSPXSE-WIPMOJCBSA-N 0.000 description 2
• 102100024148 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Human genes 0.000 description 2
• 102100024150 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial Human genes 0.000 description 2
• 235000011054 acetic acid Nutrition 0.000 description 2
• 208000026935 allergic disease Diseases 0.000 description 2
• 150000001412 amines Chemical class 0.000 description 2
• 230000000781 anti-lymphocytic effect Effects 0.000 description 2
• 230000000340 anti-metabolite Effects 0.000 description 2
• 230000000259 anti-tumor effect Effects 0.000 description 2
• 229940100197 antimetabolite Drugs 0.000 description 2
• 239000002256 antimetabolite Substances 0.000 description 2
• 238000001815 biotherapy Methods 0.000 description 2
• 210000001124 body fluid Anatomy 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 239000007853 buffer solution Substances 0.000 description 2
• 230000024245 cell differentiation Effects 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 208000037976 chronic inflammation Diseases 0.000 description 2
• 230000006020 chronic inflammation Effects 0.000 description 2
• 229960001265 ciclosporin Drugs 0.000 description 2
• 239000000470 constituent Substances 0.000 description 2
• VPUGDVKSAQVFFS-UHFFFAOYSA-N coronene Chemical compound C1=C(C2=C34)C=CC3=CC=C(C=C3)C4=C4C3=CC=C(C=C3)C4=C2C3=C1 VPUGDVKSAQVFFS-UHFFFAOYSA-N 0.000 description 2
• 230000002596 correlated effect Effects 0.000 description 2
• 230000000875 corresponding effect Effects 0.000 description 2
• 230000001186 cumulative effect Effects 0.000 description 2
• 229930182912 cyclosporin Natural products 0.000 description 2
• 210000000172 cytosol Anatomy 0.000 description 2
• 230000001627 detrimental effect Effects 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• 208000037765 diseases and disorders Diseases 0.000 description 2
• 238000001647 drug administration Methods 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 210000002889 endothelial cell Anatomy 0.000 description 2
• 210000003989 endothelium vascular Anatomy 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 229940105423 erythropoietin Drugs 0.000 description 2
• 238000000605 extraction Methods 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 230000002550 fecal effect Effects 0.000 description 2
• 238000001215 fluorescent labelling Methods 0.000 description 2
• 239000011888 foil Substances 0.000 description 2
• 230000037433 frameshift Effects 0.000 description 2
• 108020001507 fusion proteins Proteins 0.000 description 2
• 102000037865 fusion proteins Human genes 0.000 description 2
• YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 2
• KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
• 208000024908 graft versus host disease Diseases 0.000 description 2
• 210000003714 granulocyte Anatomy 0.000 description 2
• 229940093915 gynecological organic acid Drugs 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 239000012456 homogeneous solution Substances 0.000 description 2
• 102000051143 human CRP Human genes 0.000 description 2
• 102000052611 human IL6 Human genes 0.000 description 2
• 102000058177 human TNFSF12 Human genes 0.000 description 2
• 102000058223 human VEGFA Human genes 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 230000001506 immunosuppresive effect Effects 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 201000008638 inflammatory bowel disease 1 Diseases 0.000 description 2
• 230000028709 inflammatory response Effects 0.000 description 2
• 238000013101 initial test Methods 0.000 description 2
• 238000011221 initial treatment Methods 0.000 description 2
• 108010054372 insulin receptor-related receptor Proteins 0.000 description 2
• 210000004347 intestinal mucosa Anatomy 0.000 description 2
• 210000000936 intestine Anatomy 0.000 description 2
• XMBWDFGMSWQBCA-YPZZEJLDSA-N iodane Chemical compound [125IH] XMBWDFGMSWQBCA-YPZZEJLDSA-N 0.000 description 2
• 150000002540 isothiocyanates Chemical class 0.000 description 2
• 210000002510 keratinocyte Anatomy 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 238000009115 maintenance therapy Methods 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 229960001428 mercaptopurine Drugs 0.000 description 2
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
• 230000005012 migration Effects 0.000 description 2
• 238000013508 migration Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 239000003068 molecular probe Substances 0.000 description 2
• GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 2
• 229940032018 neurotrophin 3 Drugs 0.000 description 2
• 229940097998 neurotrophin 4 Drugs 0.000 description 2
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
• 210000004940 nucleus Anatomy 0.000 description 2
• XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 2
• 229920001542 oligosaccharide Polymers 0.000 description 2
• 150000002482 oligosaccharides Chemical class 0.000 description 2
• 235000005985 organic acids Nutrition 0.000 description 2
• IJTNSXPMYKJZPR-UHFFFAOYSA-N parinaric acid Chemical compound CCC=CC=CC=CC=CCCCCCCCC(O)=O IJTNSXPMYKJZPR-UHFFFAOYSA-N 0.000 description 2
• ACNHBCIZLNNLRS-UBGQALKQSA-N paxilline Chemical compound N1C2=CC=CC=C2C2=C1[C@]1(C)[C@@]3(C)CC[C@@H]4O[C@H](C(C)(O)C)C(=O)C=C4[C@]3(O)CC[C@H]1C2 ACNHBCIZLNNLRS-UBGQALKQSA-N 0.000 description 2
• 238000012302 perinuclear staining Methods 0.000 description 2
• 230000001766 physiological effect Effects 0.000 description 2
• 108090000102 pigment epithelium-derived factor Proteins 0.000 description 2
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 108090000468 progesterone receptors Proteins 0.000 description 2
• 238000004393 prognosis Methods 0.000 description 2
• 230000005855 radiation Effects 0.000 description 2
• 238000003156 radioimmunoprecipitation Methods 0.000 description 2
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 2
• 108010014186 ras Proteins Proteins 0.000 description 2
• 102000016914 ras Proteins Human genes 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 230000004043 responsiveness Effects 0.000 description 2
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
• GUAFOGOEJLSQBT-UHFFFAOYSA-N scoparone Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• 229960002930 sirolimus Drugs 0.000 description 2
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
• 210000001258 synovial membrane Anatomy 0.000 description 2
• 210000005222 synovial tissue Anatomy 0.000 description 2
• 229960003087 tioguanine Drugs 0.000 description 2
• 230000001131 transforming effect Effects 0.000 description 2
• VQTBINYMFPKLQD-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-(3-hydroxy-6-oxoxanthen-9-yl)benzoate Chemical compound C=12C=CC(=O)C=C2OC2=CC(O)=CC=C2C=1C1=CC=CC=C1C(=O)ON1C(=O)CCC1=O VQTBINYMFPKLQD-UHFFFAOYSA-N 0.000 description 1
• MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
• BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
• RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
• AYDAHOIUHVUJHQ-UHFFFAOYSA-N 1-(3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-yl)pyrrole-2,5-dione Chemical compound C=1C(O)=CC=C2C=1OC1=CC(O)=CC=C1C2(C1=CC=2)OC(=O)C1=CC=2N1C(=O)C=CC1=O AYDAHOIUHVUJHQ-UHFFFAOYSA-N 0.000 description 1
• FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
• PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
• OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 description 1
• GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
• WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 description 1
• VNEOHNUYPRAJMX-UHFFFAOYSA-N 3-[[2-[[2-amino-3-(1h-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-[[1-(butoxycarbonylamino)-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid Chemical compound C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(CC(C)C)C(=O)NC(CC(O)=O)C(=O)NC(C(=O)NC(=O)OCCCC)CC1=CC=CC=C1 VNEOHNUYPRAJMX-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
• XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
• IZWQPBUIXGHLMT-UHFFFAOYSA-N 4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]-n,n-dipentylaniline Chemical compound C1=CC(N(CCCCC)CCCCC)=CC=C1C=CC1=CC=[N+](C)C=C1 IZWQPBUIXGHLMT-UHFFFAOYSA-N 0.000 description 1
• GBPBPEPUZCTZLS-UHFFFAOYSA-M 4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]-n,n-dipentylaniline;iodide Chemical compound [I-].C1=CC(N(CCCCC)CCCCC)=CC=C1\C=C\C1=CC=[N+](C)C=C1 GBPBPEPUZCTZLS-UHFFFAOYSA-M 0.000 description 1
• YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
• RBCCQATUVPNPGQ-UHFFFAOYSA-N 4-hexadecylaniline Chemical compound CCCCCCCCCCCCCCCCC1=CC=C(N)C=C1 RBCCQATUVPNPGQ-UHFFFAOYSA-N 0.000 description 1
• ZKARERKEBVSZCX-VMDDUYISSA-M 4-methylbenzenesulfonate;trimethyl-[4-[(1e,3e,5e)-6-phenylhexa-1,3,5-trienyl]phenyl]azanium Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC([N+](C)(C)C)=CC=C1\C=C\C=C\C=C\C1=CC=CC=C1 ZKARERKEBVSZCX-VMDDUYISSA-M 0.000 description 1
• GZAJOEGTZDUSKS-UHFFFAOYSA-N 5-aminofluorescein Chemical class C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(N)=CC=C21 GZAJOEGTZDUSKS-UHFFFAOYSA-N 0.000 description 1
• YERWMQJEYUIJBO-UHFFFAOYSA-N 5-chlorosulfonyl-2-[3-(diethylamino)-6-diethylazaniumylidenexanthen-9-yl]benzenesulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(Cl)(=O)=O)C=C1S([O-])(=O)=O YERWMQJEYUIJBO-UHFFFAOYSA-N 0.000 description 1
• VTRBOZNMGVDGHY-UHFFFAOYSA-N 6-(4-methylanilino)naphthalene-2-sulfonic acid Chemical compound C1=CC(C)=CC=C1NC1=CC=C(C=C(C=C2)S(O)(=O)=O)C2=C1 VTRBOZNMGVDGHY-UHFFFAOYSA-N 0.000 description 1
• MHJZYMCYLFGDRD-KQYNXXCUSA-N 6-Mercaptopurine ribonucleoside 5'-diphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(NC=NC2=S)=C2N=C1 MHJZYMCYLFGDRD-KQYNXXCUSA-N 0.000 description 1
• GQNRDWAOABGWGP-KQYNXXCUSA-N 6-Mercaptopurine ribonucleoside triphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(NC=NC2=S)=C2N=C1 GQNRDWAOABGWGP-KQYNXXCUSA-N 0.000 description 1
• BPZXYEUJBFHASJ-UUOKFMHZSA-N 6-Thioguanosine monophosphate Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O BPZXYEUJBFHASJ-UUOKFMHZSA-N 0.000 description 1
• WMRIOGFRJLQENF-UUOKFMHZSA-N 6-Thioxanthine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC(=O)NC2=S)=C2N=C1 WMRIOGFRJLQENF-UUOKFMHZSA-N 0.000 description 1
• ZDRFDHHANOYUTE-IOSLPCCCSA-N 6-methylthioinosine Chemical compound C1=NC=2C(SC)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O ZDRFDHHANOYUTE-IOSLPCCCSA-N 0.000 description 1
• NKGPJODWTZCHGF-KQYNXXCUSA-N 6-thioinosinic acid Chemical class O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(S)=C2N=C1 NKGPJODWTZCHGF-KQYNXXCUSA-N 0.000 description 1
• 108010013238 70-kDa Ribosomal Protein S6 Kinases Proteins 0.000 description 1
• ZKRFOXLVOKTUTA-KQYNXXCUSA-N 9-(5-phosphoribofuranosyl)-6-mercaptopurine Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=S)=C2N=C1 ZKRFOXLVOKTUTA-KQYNXXCUSA-N 0.000 description 1
• NWYWQXDBECLBTR-UUOKFMHZSA-N 9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-sulfanylidene-3h-purin-2-one Chemical class O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(NC(=O)NC2=S)=C2N=C1 NWYWQXDBECLBTR-UUOKFMHZSA-N 0.000 description 1
• 101800000263 Acidic protein Proteins 0.000 description 1
• 102100031786 Adiponectin Human genes 0.000 description 1
• 108010076365 Adiponectin Proteins 0.000 description 1
• 206010067484 Adverse reaction Diseases 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
• 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
• 206010002199 Anaphylactic shock Diseases 0.000 description 1
• 102100032187 Androgen receptor Human genes 0.000 description 1
• 102000007592 Apolipoproteins Human genes 0.000 description 1
• 108010071619 Apolipoproteins Proteins 0.000 description 1
• 241000893512 Aquifex aeolicus Species 0.000 description 1
• 101001053395 Arabidopsis thaliana Acid beta-fructofuranosidase 4, vacuolar Proteins 0.000 description 1
• 208000006820 Arthralgia Diseases 0.000 description 1
• BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 1
• FTEDXVNDVHYDQW-UHFFFAOYSA-N BAPTA Chemical compound OC(=O)CN(CC(O)=O)C1=CC=CC=C1OCCOC1=CC=CC=C1N(CC(O)=O)CC(O)=O FTEDXVNDVHYDQW-UHFFFAOYSA-N 0.000 description 1
• PCLCDPVEEFVAAQ-UHFFFAOYSA-N BCA 1 Chemical compound CC(CO)CCCC(C)C1=CCC(C)(O)C1CC2=C(O)C(O)CCC2=O PCLCDPVEEFVAAQ-UHFFFAOYSA-N 0.000 description 1
• 241000606125 Bacteroides Species 0.000 description 1
• 102100036597 Basement membrane-specific heparan sulfate proteoglycan core protein Human genes 0.000 description 1
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 241000605900 Butyrivibrio fibrisolvens Species 0.000 description 1
• 101710112613 C-C motif chemokine 13 Proteins 0.000 description 1
• 102100023698 C-C motif chemokine 17 Human genes 0.000 description 1
• 102100036842 C-C motif chemokine 19 Human genes 0.000 description 1
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
• 101710112538 C-C motif chemokine 27 Proteins 0.000 description 1
• 101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
• 101710155833 C-C motif chemokine 8 Proteins 0.000 description 1
• 101710098272 C-X-C motif chemokine 11 Proteins 0.000 description 1
• 102100025250 C-X-C motif chemokine 14 Human genes 0.000 description 1
• 102100039398 C-X-C motif chemokine 2 Human genes 0.000 description 1
• 102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 1
• 101710085504 C-X-C motif chemokine 6 Proteins 0.000 description 1
• 101710085500 C-X-C motif chemokine 9 Proteins 0.000 description 1
• 102100024080 CASP8-associated protein 2 Human genes 0.000 description 1
• 108010018054 CBir1 flagellin Proteins 0.000 description 1
• 101150049756 CCL6 gene Proteins 0.000 description 1
• 101150011672 CCL9 gene Proteins 0.000 description 1
• 206010006895 Cachexia Diseases 0.000 description 1
• 101100150099 Caenorhabditis elegans spk-1 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
• 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
• 102000000584 Calmodulin Human genes 0.000 description 1
• 108010041952 Calmodulin Proteins 0.000 description 1
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 1
• 101150075117 Ccl12 gene Proteins 0.000 description 1
• 102000011068 Cdc42 Human genes 0.000 description 1
• 108050001278 Cdc42 Proteins 0.000 description 1
• 102100024649 Cell adhesion molecule 1 Human genes 0.000 description 1
• 102100024646 Cell adhesion molecule 2 Human genes 0.000 description 1
• 102100024046 Cell adhesion molecule 3 Human genes 0.000 description 1
• 102100024045 Cell adhesion molecule 4 Human genes 0.000 description 1
• 108010075016 Ceruloplasmin Proteins 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 108010082155 Chemokine CCL18 Proteins 0.000 description 1
• 108010083647 Chemokine CCL24 Proteins 0.000 description 1
• 108010083698 Chemokine CCL26 Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 102100029375 Crk-like protein Human genes 0.000 description 1
• 108050006400 Cyclin Proteins 0.000 description 1
• 102000016736 Cyclin Human genes 0.000 description 1
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
• RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
• ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
• GSFDOOHGKOHDEL-UHFFFAOYSA-N Dalpanitin Natural products COc1cc(ccc1O)C2=COc3c(C4OC(CO)C(O)C(O)C4O)c(O)cc(O)c3C2=O GSFDOOHGKOHDEL-UHFFFAOYSA-N 0.000 description 1
• 206010067671 Disease complication Diseases 0.000 description 1
• 206010061819 Disease recurrence Diseases 0.000 description 1
• 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
• 102100023274 Dual specificity mitogen-activated protein kinase kinase 4 Human genes 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 101710139422 Eotaxin Proteins 0.000 description 1
• 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
• 241000402754 Erythranthe moschata Species 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 1
• 108091008794 FGF receptors Proteins 0.000 description 1
• 108010054218 Factor VIII Proteins 0.000 description 1
• 102000001690 Factor VIII Human genes 0.000 description 1
• 102000008857 Ferritin Human genes 0.000 description 1
• 108050000784 Ferritin Proteins 0.000 description 1
• 238000008416 Ferritin Methods 0.000 description 1
• 102000008946 Fibrinogen Human genes 0.000 description 1
• 108010049003 Fibrinogen Proteins 0.000 description 1
• 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 1
• 101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 1
• 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 1
• 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 description 1
• 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 1
• 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 1
• 102100027844 Fibroblast growth factor receptor 4 Human genes 0.000 description 1
• 238000000729 Fisher's exact test Methods 0.000 description 1
• 101710151190 Flagellin A Proteins 0.000 description 1
• 102100037740 GRB2-associated-binding protein 1 Human genes 0.000 description 1
• 101710113436 GTPase KRas Proteins 0.000 description 1
• 102100039788 GTPase NRas Human genes 0.000 description 1
• 101710115997 Gamma-tubulin complex component 2 Proteins 0.000 description 1
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
• 206010056740 Genital discharge Diseases 0.000 description 1
• 108010072051 Glatiramer Acetate Proteins 0.000 description 1
• 102000003676 Glucocorticoid Receptors Human genes 0.000 description 1
• 108090000079 Glucocorticoid Receptors Proteins 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 1
• 238000010268 HPLC based assay Methods 0.000 description 1
• 108050005077 Haptoglobin Proteins 0.000 description 1
• 102000014702 Haptoglobin Human genes 0.000 description 1
• 241000589989 Helicobacter Species 0.000 description 1
• 241000590006 Helicobacter mustelae Species 0.000 description 1
• 241000590002 Helicobacter pylori Species 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 102100022623 Hepatocyte growth factor receptor Human genes 0.000 description 1
• 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 description 1
• 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 description 1
• 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 1
• 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 description 1
• 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 description 1
• 101000713078 Homo sapiens C-C motif chemokine 24 Proteins 0.000 description 1
• 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
• 101000897494 Homo sapiens C-C motif chemokine 27 Proteins 0.000 description 1
• 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 1
• 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 description 1
• 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 description 1
• 101000858068 Homo sapiens C-X-C motif chemokine 14 Proteins 0.000 description 1
• 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 description 1
• 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 1
• 101000947177 Homo sapiens C-X-C motif chemokine 6 Proteins 0.000 description 1
• 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 description 1
• 101000910382 Homo sapiens CASP8-associated protein 2 Proteins 0.000 description 1
• 101100005560 Homo sapiens CCL23 gene Proteins 0.000 description 1
• 101000919315 Homo sapiens Crk-like protein Proteins 0.000 description 1
• 101000920800 Homo sapiens Endoplasmic reticulum-Golgi intermediate compartment protein 2 Proteins 0.000 description 1
• 101000978392 Homo sapiens Eotaxin Proteins 0.000 description 1
• 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 1
• 101000917134 Homo sapiens Fibroblast growth factor receptor 4 Proteins 0.000 description 1
• 101001024897 Homo sapiens GRB2-associated-binding protein 1 Proteins 0.000 description 1
• 101000744505 Homo sapiens GTPase NRas Proteins 0.000 description 1
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 1
• 101000972946 Homo sapiens Hepatocyte growth factor receptor Proteins 0.000 description 1
• 101000606465 Homo sapiens Inactive tyrosine-protein kinase 7 Proteins 0.000 description 1
• 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
• 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 1
• 101001005128 Homo sapiens LIM domain kinase 1 Proteins 0.000 description 1
• 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 description 1
• 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 description 1
• 101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 description 1
• 101000604565 Homo sapiens Phosphatidylinositol glycan anchor biosynthesis class U protein Proteins 0.000 description 1
• 101001073422 Homo sapiens Pigment epithelium-derived factor Proteins 0.000 description 1
• 101000583156 Homo sapiens Pituitary homeobox 1 Proteins 0.000 description 1
• 101000582950 Homo sapiens Platelet factor 4 Proteins 0.000 description 1
• 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 description 1
• 101000586618 Homo sapiens Poliovirus receptor Proteins 0.000 description 1
• 101000851176 Homo sapiens Pro-epidermal growth factor Proteins 0.000 description 1
• 101000878540 Homo sapiens Protein-tyrosine kinase 2-beta Proteins 0.000 description 1
• 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 1
• 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 1
• 101100369997 Homo sapiens TNFSF12 gene Proteins 0.000 description 1
• 101000933296 Homo sapiens Transcription factor TFIIIB component B'' homolog Proteins 0.000 description 1
• 101001087394 Homo sapiens Tyrosine-protein phosphatase non-receptor type 1 Proteins 0.000 description 1
• 101001087422 Homo sapiens Tyrosine-protein phosphatase non-receptor type 13 Proteins 0.000 description 1
• 101001087412 Homo sapiens Tyrosine-protein phosphatase non-receptor type 18 Proteins 0.000 description 1
• 101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 description 1
• 101100273566 Humulus lupulus CCL10 gene Proteins 0.000 description 1
• HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102100039813 Inactive tyrosine-protein kinase 7 Human genes 0.000 description 1
• 108010001127 Insulin Receptor Proteins 0.000 description 1
• 206010022489 Insulin Resistance Diseases 0.000 description 1
• 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 description 1
• 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 description 1
• 102100037874 Intercellular adhesion molecule 4 Human genes 0.000 description 1
• 101710148793 Intercellular adhesion molecule 4 Proteins 0.000 description 1
• 102100039919 Intercellular adhesion molecule 5 Human genes 0.000 description 1
• 101710148796 Intercellular adhesion molecule 5 Proteins 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 102100039065 Interleukin-1 beta Human genes 0.000 description 1
• 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 description 1
• 101710144554 Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 108010066979 Interleukin-27 Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102000000743 Interleukin-5 Human genes 0.000 description 1
• 102100026019 Interleukin-6 Human genes 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
• 108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 1
• 102000019145 JUN kinase activity proteins Human genes 0.000 description 1
• 108040006417 JUN kinase kinase activity proteins Proteins 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• 102100026023 LIM domain kinase 1 Human genes 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 102000016267 Leptin Human genes 0.000 description 1
• 108010092277 Leptin Proteins 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 102000001291 MAP Kinase Kinase Kinase Human genes 0.000 description 1
• 108060006687 MAP kinase kinase kinase Proteins 0.000 description 1
• 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 1
• 101710150918 Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 1
• WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
• 102000009112 Mannose-Binding Lectin Human genes 0.000 description 1
• 108010087870 Mannose-Binding Lectin Proteins 0.000 description 1
• 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
• 101710087603 Mast/stem cell growth factor receptor Kit Proteins 0.000 description 1
• 108090000375 Mineralocorticoid Receptors Proteins 0.000 description 1
• 102100021316 Mineralocorticoid receptor Human genes 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101000978374 Mus musculus C-C motif chemokine 12 Proteins 0.000 description 1
• 101100222387 Mus musculus Cxcl15 gene Proteins 0.000 description 1
• 101100268066 Mus musculus Zap70 gene Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
• 208000000112 Myalgia Diseases 0.000 description 1
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
• 101100454133 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) kstR2 gene Proteins 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 108010013731 Myelin-Associated Glycoprotein Proteins 0.000 description 1
• 102000017099 Myelin-Associated Glycoprotein Human genes 0.000 description 1
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
• HRNLUBSXIHFDHP-UHFFFAOYSA-N N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide Chemical compound NC1=CC=CC=C1NC(=O)C(C=C1)=CC=C1CNC1=NC=CC(C=2C=NC=CC=2)=N1 HRNLUBSXIHFDHP-UHFFFAOYSA-N 0.000 description 1
• CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
• 206010028851 Necrosis Diseases 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 102000007072 Nerve Growth Factors Human genes 0.000 description 1
• 102000015532 Nicotinamide phosphoribosyltransferase Human genes 0.000 description 1
• 108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• 108020004485 Nonsense Codon Proteins 0.000 description 1
• 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
• 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
• 102000011244 Nuclear receptor coactivator Human genes 0.000 description 1
• 108050001461 Nuclear receptor coactivator Proteins 0.000 description 1
• 108091005461 Nucleic proteins Chemical group 0.000 description 1
• 102000016978 Orphan receptors Human genes 0.000 description 1
• 108070000031 Orphan receptors Proteins 0.000 description 1
• 101710203379 Outer membrane porin C Proteins 0.000 description 1
• 101710160101 Outer membrane protein C Proteins 0.000 description 1
• 208000002193 Pain Diseases 0.000 description 1
• 101710161551 Pectate lyase 3 Proteins 0.000 description 1
• KJWMGLBVDNMNQW-VWTMXFPPSA-N Pectenotoxin 1 Chemical compound O[C@@H]1[C@H](C)CCO[C@]1(O)[C@H]1O[C@@H]2/C=C/C(/C)=C/[C@H](C)C[C@](C)(O3)CC[C@@H]3[C@](O3)(O4)CC[C@@]3(CO)C[C@@H]4[C@@H](O3)C(=O)C[C@]3(C)[C@@H](O)[C@@H](O3)CC[C@@]3(O3)CCC[C@H]3[C@@H](C)C(=O)O[C@@H]2C1 KJWMGLBVDNMNQW-VWTMXFPPSA-N 0.000 description 1
• 206010057249 Phagocytosis Diseases 0.000 description 1
• 102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 description 1
• 102100026918 Phospholipase A2 Human genes 0.000 description 1
• 101710096328 Phospholipase A2 Proteins 0.000 description 1
• 101710124951 Phospholipase C Proteins 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 108010051456 Plasminogen Proteins 0.000 description 1
• 102000013566 Plasminogen Human genes 0.000 description 1
• 108090000778 Platelet factor 4 Proteins 0.000 description 1
• 102100029740 Poliovirus receptor Human genes 0.000 description 1
• 108010071690 Prealbumin Proteins 0.000 description 1
• 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 101710179609 Probable pectin lyase C Proteins 0.000 description 1
• 206010036790 Productive cough Diseases 0.000 description 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
• 102000003923 Protein Kinase C Human genes 0.000 description 1
• 108090000315 Protein Kinase C Proteins 0.000 description 1
• 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 102100037787 Protein-tyrosine kinase 2-beta Human genes 0.000 description 1
• 108010094028 Prothrombin Proteins 0.000 description 1
• 102100027378 Prothrombin Human genes 0.000 description 1
• 101000658294 Rattus norvegicus Thioredoxin-like protein 1 Proteins 0.000 description 1
• 101100046535 Rattus norvegicus Tnf gene Proteins 0.000 description 1
• 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 1
• 102000007156 Resistin Human genes 0.000 description 1
• 108010047909 Resistin Proteins 0.000 description 1
• 241000219061 Rheum Species 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 108060006706 SRC Proteins 0.000 description 1
• 102000001332 SRC Human genes 0.000 description 1
• 241000235070 Saccharomyces Species 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 101000744436 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Trans-acting factor D Proteins 0.000 description 1
• 241000582914 Saccharomyces uvarum Species 0.000 description 1
• 101100173587 Schizosaccharomyces pombe (strain 972 / ATCC 24843) fft3 gene Proteins 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 102100040293 Serine/threonine-protein kinase LMTK1 Human genes 0.000 description 1
• 101710118516 Serine/threonine-protein kinase LMTK1 Proteins 0.000 description 1
• 108010045517 Serum Amyloid P-Component Proteins 0.000 description 1
• 102100036202 Serum amyloid P-component Human genes 0.000 description 1
• 108010029176 Sialic Acid Binding Ig-like Lectin 1 Proteins 0.000 description 1
• 108010029157 Sialic Acid Binding Ig-like Lectin 2 Proteins 0.000 description 1
• 108010029180 Sialic Acid Binding Ig-like Lectin 3 Proteins 0.000 description 1
• 108010047827 Sialic Acid Binding Immunoglobulin-like Lectins Proteins 0.000 description 1
• 102000007073 Sialic Acid Binding Immunoglobulin-like Lectins Human genes 0.000 description 1
• 102100032855 Sialoadhesin Human genes 0.000 description 1
• 241000144290 Sigmodon hispidus Species 0.000 description 1
• 101710088580 Stromal cell-derived factor 1 Proteins 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
• CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 description 1
• 102100024547 Tensin-1 Human genes 0.000 description 1
• MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 1
• 102000014034 Transcortin Human genes 0.000 description 1
• 108010011095 Transcortin Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 102000009190 Transthyretin Human genes 0.000 description 1
• 101000638142 Treponema pallidum (strain Nichols) Membrane lipoprotein TmpC Proteins 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 101710098580 Tubulin gamma-1 chain Proteins 0.000 description 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
• 102100033001 Tyrosine-protein phosphatase non-receptor type 1 Human genes 0.000 description 1
• 102100033019 Tyrosine-protein phosphatase non-receptor type 11 Human genes 0.000 description 1
• 101710116241 Tyrosine-protein phosphatase non-receptor type 11 Proteins 0.000 description 1
• 102100033014 Tyrosine-protein phosphatase non-receptor type 13 Human genes 0.000 description 1
• 102100033018 Tyrosine-protein phosphatase non-receptor type 18 Human genes 0.000 description 1
• LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 1
• LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
• TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
• 102000008790 VE-cadherin Human genes 0.000 description 1
• 238000005411 Van der Waals force Methods 0.000 description 1
• 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 102100025093 Zinc fingers and homeoboxes protein 2 Human genes 0.000 description 1
• UJWXUYJNIOWTSZ-UUOKFMHZSA-N [(2r,3s,4r,5r)-3,4-dihydroxy-5-(2-oxo-6-sulfanylidene-3h-purin-9-yl)oxolan-2-yl]methyl phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(NC(=O)NC2=S)=C2N=C1 UJWXUYJNIOWTSZ-UUOKFMHZSA-N 0.000 description 1
• KTKAFSMJDTUUAN-UUOKFMHZSA-N [(2r,3s,4r,5r)-5-(4-carbamoyl-5-hydroxyimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound OC1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 KTKAFSMJDTUUAN-UUOKFMHZSA-N 0.000 description 1
• IHBCFWWEZXPPLG-UHFFFAOYSA-N [Ca].[Zn] Chemical compound [Ca].[Zn] IHBCFWWEZXPPLG-UHFFFAOYSA-N 0.000 description 1
• ORGFIHNPBOUBNH-UUOKFMHZSA-N [[(2r,3s,4r,5r)-3,4-dihydroxy-5-(2-oxo-6-sulfanylidene-3h-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(NC(=O)NC2=S)=C2N=C1 ORGFIHNPBOUBNH-UUOKFMHZSA-N 0.000 description 1
• FHEAIOHRHQGZPC-KIWGSFCNSA-N acetic acid;(2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-aminopentanedioic acid;(2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FHEAIOHRHQGZPC-KIWGSFCNSA-N 0.000 description 1
• 229960001138 acetylsalicylic acid Drugs 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
• 229940119059 actemra Drugs 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000004658 acute-phase response Effects 0.000 description 1
• 238000011374 additional therapy Methods 0.000 description 1
• 102000011759 adducin Human genes 0.000 description 1
• 108010076723 adducin Proteins 0.000 description 1
• 239000000478 adipokine Substances 0.000 description 1
• 230000006838 adverse reaction Effects 0.000 description 1
• 238000007818 agglutination assay Methods 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• 108010091628 alpha 1-Antichymotrypsin Proteins 0.000 description 1
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 1
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• IJTNSXPMYKJZPR-WVRBZULHSA-N alpha-parinaric acid Natural products CCC=C/C=C/C=C/C=CCCCCCCCC(=O)O IJTNSXPMYKJZPR-WVRBZULHSA-N 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• OBESRABRARNZJB-UHFFFAOYSA-N aminomethanesulfonic acid Chemical compound NCS(O)(=O)=O OBESRABRARNZJB-UHFFFAOYSA-N 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 208000003455 anaphylaxis Diseases 0.000 description 1
• 108010080146 androgen receptors Proteins 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 230000003712 anti-aging effect Effects 0.000 description 1
• 230000003110 anti-inflammatory effect Effects 0.000 description 1
• 230000000356 anti-lactoferrin effect Effects 0.000 description 1
• 230000001494 anti-thymocyte effect Effects 0.000 description 1
• 239000003435 antirheumatic agent Substances 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 230000036528 appetite Effects 0.000 description 1
• 235000019789 appetite Nutrition 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 238000013528 artificial neural network Methods 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 150000001540 azides Chemical class 0.000 description 1
• 229940064856 azulfidine Drugs 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
• 229940092714 benzenesulfonic acid Drugs 0.000 description 1
• ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
• DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
• LUEWUZLMQUOBSB-MHJOMNRISA-N beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-D-Manp Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3[C@H](OC(O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@@H](O)[C@H]1O LUEWUZLMQUOBSB-MHJOMNRISA-N 0.000 description 1
• SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 229960003237 betaine Drugs 0.000 description 1
• 210000000941 bile Anatomy 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 238000005842 biochemical reaction Methods 0.000 description 1
• 239000003124 biologic agent Substances 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 229940126587 biotherapeutics Drugs 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 230000017531 blood circulation Effects 0.000 description 1
• 238000004820 blood count Methods 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 230000006583 body weight regulation Effects 0.000 description 1
• 229940112869 bone morphogenetic protein Drugs 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 239000004327 boric acid Substances 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 108010018828 cadherin 5 Proteins 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 230000004094 calcium homeostasis Effects 0.000 description 1
• 229940095731 candida albicans Drugs 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 210000004534 cecum Anatomy 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
• 150000005829 chemical entities Chemical class 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 239000013626 chemical specie Substances 0.000 description 1
• JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
• 229960004630 chlorambucil Drugs 0.000 description 1
• FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
• 229940106681 chloroacetic acid Drugs 0.000 description 1
• 210000001612 chondrocyte Anatomy 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 238000010668 complexation reaction Methods 0.000 description 1
• 239000003246 corticosteroid Substances 0.000 description 1
• 229960001334 corticosteroids Drugs 0.000 description 1
• 235000001671 coumarin Nutrition 0.000 description 1
• 150000004775 coumarins Chemical class 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 229960004397 cyclophosphamide Drugs 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 229940009976 deoxycholate Drugs 0.000 description 1
• KXGVEGMKQFWNSR-LLQZFEROSA-M deoxycholate Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-M 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 208000010643 digestive system disease Diseases 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 239000002988 disease modifying antirheumatic drug Substances 0.000 description 1
• 235000019820 disodium diphosphate Nutrition 0.000 description 1
• BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
• 238000009509 drug development Methods 0.000 description 1
• 238000012362 drug development process Methods 0.000 description 1
• 239000003480 eluent Substances 0.000 description 1
• 230000012202 endocytosis Effects 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 108010087914 epidermal growth factor receptor VIII Proteins 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
• 229960005542 ethidium bromide Drugs 0.000 description 1
• GTSMOYLSFUBTMV-UHFFFAOYSA-N ethidium homodimer Chemical compound [H+].[H+].[Cl-].[Cl-].[Cl-].[Cl-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2C(C)=[N+]1CCCNCCNCCC[N+](C1=CC(N)=CC=C1C1=CC=C(N)C=C11)=C1C1=CC=CC=C1 GTSMOYLSFUBTMV-UHFFFAOYSA-N 0.000 description 1
• DSLLHVISNOIYHR-UHFFFAOYSA-M ethyl 2-(6-methoxyquinolin-1-ium-1-yl)acetate;bromide Chemical compound [Br-].COC1=CC=C2[N+](CC(=O)OCC)=CC=CC2=C1 DSLLHVISNOIYHR-UHFFFAOYSA-M 0.000 description 1
• YTPLJUZIOGNPTJ-UHFFFAOYSA-M ethyl 2-isoquinolin-2-ium-2-ylacetate;bromide Chemical compound [Br-].C1=CC=CC2=C[N+](CC(=O)OCC)=CC=C21 YTPLJUZIOGNPTJ-UHFFFAOYSA-M 0.000 description 1
• RYNBQQWODYCGRR-UHFFFAOYSA-N ethyl 5-(4-chlorophenyl)-2-methyl-1-phenylpyrrole-3-carboxylate Chemical compound C=1C=CC=CC=1N1C(C)=C(C(=O)OCC)C=C1C1=CC=C(Cl)C=C1 RYNBQQWODYCGRR-UHFFFAOYSA-N 0.000 description 1
• WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
• 229960005293 etodolac Drugs 0.000 description 1
• XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 229960005167 everolimus Drugs 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 239000011536 extraction buffer Substances 0.000 description 1
• 229960000301 factor viii Drugs 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 210000003608 fece Anatomy 0.000 description 1
• 108010052295 fibrin fragment D Proteins 0.000 description 1
• 229940012952 fibrinogen Drugs 0.000 description 1
• 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 108010003342 flaB flagellin Proteins 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 125000003983 fluorenyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 238000005558 fluorometry Methods 0.000 description 1
• 229950004923 fontolizumab Drugs 0.000 description 1
• 235000019253 formic acid Nutrition 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 231100000221 frame shift mutation induction Toxicity 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• YFHXZQPUBCBNIP-UHFFFAOYSA-N fura-2 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=3OC(=CC=3C=2)C=2OC(=CN=2)C(O)=O)N(CC(O)=O)CC(O)=O)=C1 YFHXZQPUBCBNIP-UHFFFAOYSA-N 0.000 description 1
• 238000001641 gel filtration chromatography Methods 0.000 description 1
• 210000004907 gland Anatomy 0.000 description 1
• 229960003776 glatiramer acetate Drugs 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 229940045883 glutathione disulfide Drugs 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 229940037467 helicobacter pylori Drugs 0.000 description 1
• 230000011132 hemopoiesis Effects 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 102000050459 human LTF Human genes 0.000 description 1
• 102000050354 human NOD2 Human genes 0.000 description 1
• 210000003917 human chromosome Anatomy 0.000 description 1
• 229940116978 human epidermal growth factor Drugs 0.000 description 1
• 210000004408 hybridoma Anatomy 0.000 description 1
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
• GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
• 150000002432 hydroperoxides Chemical class 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 229960001680 ibuprofen Drugs 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000000984 immunochemical effect Effects 0.000 description 1
• 229940127121 immunoconjugate Drugs 0.000 description 1
• 230000000951 immunodiffusion Effects 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 229940124541 immunological agent Drugs 0.000 description 1
• 238000002650 immunosuppressive therapy Methods 0.000 description 1
• 230000001024 immunotherapeutic effect Effects 0.000 description 1
• 239000002596 immunotoxin Substances 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 238000011503 in vivo imaging Methods 0.000 description 1
• 229910052738 indium Inorganic materials 0.000 description 1
• 229940055742 indium-111 Drugs 0.000 description 1
• APFVFJFRJDLVQX-AHCXROLUSA-N indium-111 Chemical compound [111In] APFVFJFRJDLVQX-AHCXROLUSA-N 0.000 description 1
• MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 230000005732 intercellular adhesion Effects 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 229940044173 iodine-125 Drugs 0.000 description 1
• PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
• JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 229910052747 lanthanoid Inorganic materials 0.000 description 1
• 150000002602 lanthanoids Chemical class 0.000 description 1
• 150000002605 large molecules Chemical class 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 229940039781 leptin Drugs 0.000 description 1
• NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 238000002761 liquid phase assay Methods 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 208000030208 low-grade fever Diseases 0.000 description 1
• DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 238000010801 machine learning Methods 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 239000001630 malic acid Substances 0.000 description 1
• 235000011090 malic acid Nutrition 0.000 description 1
• 229940118019 malondialdehyde Drugs 0.000 description 1
• LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 1
• 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• 210000002752 melanocyte Anatomy 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
• 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
• 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
• 210000003097 mucus Anatomy 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 229940014456 mycophenolate Drugs 0.000 description 1
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
• SHXOKQKTZJXHHR-UHFFFAOYSA-N n,n-diethyl-5-iminobenzo[a]phenoxazin-9-amine;hydrochloride Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=[NH2+])C2=C1 SHXOKQKTZJXHHR-UHFFFAOYSA-N 0.000 description 1
• DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
• 125000001624 naphthyl group Chemical group 0.000 description 1
• 229960002009 naproxen Drugs 0.000 description 1
• CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
• 230000017074 necrotic cell death Effects 0.000 description 1
• 238000013188 needle biopsy Methods 0.000 description 1
• 210000000933 neural crest Anatomy 0.000 description 1
• 210000004498 neuroglial cell Anatomy 0.000 description 1
• 239000003900 neurotrophic factor Substances 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 230000003448 neutrophilic effect Effects 0.000 description 1
• 239000002547 new drug Substances 0.000 description 1
• 210000000019 nipple aspirate fluid Anatomy 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• 102000037979 non-receptor tyrosine kinases Human genes 0.000 description 1
• 108091008046 non-receptor tyrosine kinases Proteins 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 150000002894 organic compounds Chemical class 0.000 description 1
• 235000006408 oxalic acid Nutrition 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 1
• 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 102000041715 pentraxin family Human genes 0.000 description 1
• 108091075331 pentraxin family Proteins 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 210000003516 pericardium Anatomy 0.000 description 1
• 150000002978 peroxides Chemical class 0.000 description 1
• 230000008782 phagocytosis Effects 0.000 description 1
• IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
• INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
• 230000036470 plasma concentration Effects 0.000 description 1
• 102000054765 polymorphisms of proteins Human genes 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000034190 positive regulation of NF-kappaB transcription factor activity Effects 0.000 description 1
• 231100000683 possible toxicity Toxicity 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 150000003141 primary amines Chemical class 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 229940002612 prodrug Drugs 0.000 description 1
• 239000000651 prodrug Substances 0.000 description 1
• 208000037821 progressive disease Diseases 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• 238000002731 protein assay Methods 0.000 description 1
• 235000004252 protein component Nutrition 0.000 description 1
• 230000006318 protein oxidation Effects 0.000 description 1
• 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
• 229940039716 prothrombin Drugs 0.000 description 1
• 238000010298 pulverizing process Methods 0.000 description 1
• 238000004445 quantitative analysis Methods 0.000 description 1
• 239000002096 quantum dot Substances 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 238000007637 random forest analysis Methods 0.000 description 1
• 239000000985 reactive dye Substances 0.000 description 1
• 239000012048 reactive intermediate Substances 0.000 description 1
• 239000003642 reactive oxygen metabolite Substances 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 108010054624 red fluorescent protein Proteins 0.000 description 1
• 230000010282 redox signaling Effects 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000029892 regulation of protein phosphorylation Effects 0.000 description 1
• 201000002063 renal hypomagnesemia 4 Diseases 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000019254 respiratory burst Effects 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 102000027483 retinoid hormone receptors Human genes 0.000 description 1
• 108091008679 retinoid hormone receptors Proteins 0.000 description 1
• 102000029752 retinol binding Human genes 0.000 description 1
• 108091000053 retinol binding Proteins 0.000 description 1
• TUIHPLOAPJDCGN-UHFFFAOYSA-M rhodamine 800 Chemical compound [Cl-].C1CCN2CCCC3=C2C1=C1OC2=C(CCC4)C5=[N+]4CCCC5=CC2=C(C#N)C1=C3 TUIHPLOAPJDCGN-UHFFFAOYSA-M 0.000 description 1
• 239000011435 rock Substances 0.000 description 1
• 102220001819 rs2066847 Human genes 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 210000004116 schwann cell Anatomy 0.000 description 1
• SVHDRHWULLNMQC-UHFFFAOYSA-N scoparone Natural products C1=CC(=O)OC2=C1C=C(C(=O)C)C(C(C)=O)=C2 SVHDRHWULLNMQC-UHFFFAOYSA-N 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 210000004739 secretory vesicle Anatomy 0.000 description 1
• 238000011896 sensitive detection Methods 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• OSQUFVVXNRMSHL-LTHRDKTGSA-M sodium;3-[(2z)-2-[(e)-4-(1,3-dibutyl-4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)but-2-enylidene]-1,3-benzoxazol-3-yl]propane-1-sulfonate Chemical compound [Na+].O=C1N(CCCC)C(=S)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 OSQUFVVXNRMSHL-LTHRDKTGSA-M 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 238000012306 spectroscopic technique Methods 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 238000012421 spiking Methods 0.000 description 1
• 210000003802 sputum Anatomy 0.000 description 1
• 208000024794 sputum Diseases 0.000 description 1
• 239000012086 standard solution Substances 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 238000013517 stratification Methods 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
• 150000003460 sulfonic acids Chemical class 0.000 description 1
• YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
• 229910021653 sulphate ion Inorganic materials 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 238000012706 support-vector machine Methods 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 229960000235 temsirolimus Drugs 0.000 description 1
• QFJCIRLUMZQUOT-UHFFFAOYSA-N temsirolimus Natural products C1CC(O)C(OC)CC1CC(C)C1OC(=O)C2CCCCN2C(=O)C(=O)C(O)(O2)C(C)CCC2CC(OC)C(C)=CC=CC=CC(C)CC(C)C(=O)C(OC)C(O)C(C)=CC(C)C(=O)C1 QFJCIRLUMZQUOT-UHFFFAOYSA-N 0.000 description 1
• WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
• 230000004797 therapeutic response Effects 0.000 description 1
• ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 1
• IUTNWRFYTFZSEK-UUOKFMHZSA-N thioguanosine 5'-diphosphate Chemical compound C1=NC=2C(=S)NC(N)=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O IUTNWRFYTFZSEK-UUOKFMHZSA-N 0.000 description 1
• QENYANNAQSWPLM-UUOKFMHZSA-N thioguanosine 5'-triphosphate Chemical compound C1=NC=2C(=S)NC(N)=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O QENYANNAQSWPLM-UUOKFMHZSA-N 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
• 102000004217 thyroid hormone receptors Human genes 0.000 description 1
• 108090000721 thyroid hormone receptors Proteins 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• 229960003989 tocilizumab Drugs 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 108091008023 transcriptional regulators Proteins 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 230000014616 translation Effects 0.000 description 1
• 102000035160 transmembrane proteins Human genes 0.000 description 1
• 108091005703 transmembrane proteins Proteins 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 description 1
• 239000002452 tumor necrosis factor alpha inhibitor Substances 0.000 description 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 238000010798 ubiquitination Methods 0.000 description 1
• 230000034512 ubiquitination Effects 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 229940116269 uric acid Drugs 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 235000019155 vitamin A Nutrition 0.000 description 1
• 239000011719 vitamin A Substances 0.000 description 1
• 102000009310 vitamin D receptors Human genes 0.000 description 1
• 108050000156 vitamin D receptors Proteins 0.000 description 1
• 229940045997 vitamin a Drugs 0.000 description 1
• 108010047303 von Willebrand Factor Proteins 0.000 description 1
• 102100036537 von Willebrand factor Human genes 0.000 description 1
• 229960001134 von willebrand factor Drugs 0.000 description 1
• 239000002699 waste material Substances 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• 150000003732 xanthenes Chemical class 0.000 description 1
• 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
• 108010088577 zinc-binding protein Proteins 0.000 description 1